|NASDAQ: AHCO||Healthcare / Medical Devices & Instruments / USA|
|13.97||-0.4300||-2.99%||Vol 696.36K||1Y Perf -16.52%|
|Mar 22nd, 2023 15:40 DELAYED|
|-0.01 -0.07%||- -|
|Target Price||28.69||Analyst Rating||Strong Buy 1.13|
|Potential %||104.93||Finscreener Ranking||— -|
|Insiders Trans % 3/6/12 mo.||-/100/-||Value Ranking||★ 40.62|
|Insiders Value % 3/6/12 mo.||-/100/-38||Growth Ranking||★★+ 49.60|
|Insiders Shares Cnt. % 3/6/12 mo.||-/100/-20||Income Ranking||— -|
|Price Range Ratio 52W %||15.98||Earnings Rating||—|
|Market Cap||1.89B||Earnings Date||9th May 2023|
Today's Price Range
|Moving Averages:||Strong Sell|
|Mngmt Effectiveness||Value||Industry||S&P 500||US Markets|
ROE (5Y Avg)
ROE last 12 Months
ROA (5Y Avg)
ROA last 12 Months
ROC (5Y Avg)
ROC last 12 Months
Return on invested Capital Q
Return on invested Capital Y
|Valuation||Value||Industry||S&P 500||US Markets|
|Financial Strength||Value||Industry||S&P 500||US Markets|
|Profitability||Value||Industry||S&P 500||US Markets|
|Revenue||Value||Industry||S&P 500||US Markets|
|Dividends||Value||Industry||S&P 500||US Markets|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||9th May 2023|
|Estimated EPS Next Report||0.11|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||1.20M|
|Avg. Monthly Volume||1.79M|
|Avg. Quarterly Volume||1.01M|
AdaptHealth Corp. (NASDAQ: AHCO) stock closed at 14.4 per share at the end of the most recent trading day (a 6.67% change compared to the prior day closing price) with a volume of 1.07M shares and market capitalization of 1.89B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 3060 people. AdaptHealth Corp. CEO is Stephen P. Griggs / Luke McGee.
The one-year performance of AdaptHealth Corp. stock is -16.52%, while year-to-date (YTD) performance is -25.08%. AHCO stock has a five-year performance of %. Its 52-week range is between 11.4 and 27.48, which gives AHCO stock a 52-week price range ratio of 15.98%
AdaptHealth Corp. currently has a PE ratio of 28.90, a price-to-book (PB) ratio of 1.23, a price-to-sale (PS) ratio of 1.65, a price to cashflow ratio of 7.10, a PEG ratio of 2.32, a ROA of 1.67%, a ROC of 3.77% and a ROE of 4.20%. The company’s profit margin is 4.63%, its EBITDA margin is 19.90%, and its revenue ttm is $1.61 Billion , which makes it $11.98 revenue per share.
Of the last four earnings reports from AdaptHealth Corp., there were 0 positive earnings surprise and 4 negative earnings surprise. The company has EPS estimate of $0.11 for the next earnings report. AdaptHealth Corp.’s next earnings report date is 09th May 2023.
The consensus rating of Wall Street analysts for AdaptHealth Corp. is Strong Buy (1.13), with a target price of $28.69, which is +104.93% compared to the current price. The earnings rating for AdaptHealth Corp. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
AdaptHealth Corp. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
AdaptHealth Corp. has a Sell technical analysis rating based on Technical Indicators (ADX : 10.85, ATR14 : 0.83, CCI20 : -48.95, Chaikin Money Flow : -0.24, MACD : -1.79, Money Flow Index : 50.93, ROC : -10.00, RSI : 34.86, STOCH (14,3) : 48.37, STOCH RSI : 1.00, UO : 57.88, Williams %R : -51.63), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of AdaptHealth Corp. in the last 12-months were: Daniel Bunting (Option Excercise at a value of $1 203 119), Daniel Bunting (Sold 230 156 shares of value $5 050 750 ), David S. Williams (Sold 2 254 shares of value $40 993 ), Shaw Rietkerk (Sold 150 000 shares of value $3 378 120 )
|Analyst Ratings||Current||1 M ago||3 M ago|
|Summary Rating||Strong Buy||Strong Buy||Strong Buy|
AdaptHealth Corp is a provider of home healthcare equipment and related services. Its products portfolio includes Mobility Products, Sleep Therapy and Sleep Therapy Supplies, Respiratory Therapy, Non-invasive Ventilation, Nutrition Supplies, Bed Lifts, Seat Lift Chairs, Home Modifications, Power Mobility, and Bath Aids.
CEO: Stephen P. Griggs / Luke McGee
Telephone: +1 610 630-6357
Address: 220 West Germantown Pike, Plymouth Meeting 19462, PA, US
Number of employees: 3 060
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
General partner of Finscreener is SLOVAKODATA, a.s.
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.